Study

EORTC-62091-TRUSTS

TRUSTS : A phase IIb/III multicenter study comparing the efficacy of Trabectedin administered as a 3-hour or 24 hour infusion to doxorubicin in patients with advanced or metastatic untreated soft tissue sarcoma

Study documentation Back to result

Trial Status

All trial activities ended

Dates

Date of activation: 27-May-2011
Date Step1 close: 06-Aug-2012

Data management at EORTC

Yes

Design

Phase 2-3
Randomized open label

Targeted Sample size

EORTC Groups: 250 - All Groups: 370

Protocol summary

http://clinicaltrials.gov/study/NCT01189253

NCT number

NCT01189253

EudraCT

2009-014889-26